These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 83671)

  • 41. HLA and the response of lymphocytes to viral antigens in patients with multiple sclerosis.
    Walker JE; Cook JD; Harrison P; Stastny P
    Hum Immunol; 1982 Feb; 4(1):71-8. PubMed ID: 7061242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Multiple sclerosis in Northern-West region of Russia: results of HLA-typing].
    Odinak MM; Bisaga GN; Kalinina NM; Akimov SB; Semilutskaia IB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(2):40-4. PubMed ID: 10709290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histocompatibility antigens (HLA) in multiple sclerosis in Iran.
    Lotfi J; Nikbin B; Derakhshan I; Aghai Z; Ala F
    J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):699-701. PubMed ID: 681957
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HLA antigens in multiple sclerosis amongst Indians.
    Wadia NH; Trikannad VS; Krishnaswamy PR
    J Neurol Neurosurg Psychiatry; 1981 Sep; 44(9):849-51. PubMed ID: 7310428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Public determinants of HLA indicated by pregnancy antibodies.
    Konoeda Y; Terasaki PI; Wakisaka A; Park MS; Mickey MR
    Transplantation; 1986 Feb; 41(2):253-9. PubMed ID: 2418552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple sclerosis in Pakistan: histocompatibility antigen composition and disability.
    Wasay M; Moatter T; Mehmood K; Subhan M; Ahmed A; Tariq M; Khoso N; Shahbaz N; Awan S; Fredrikson S
    Mult Scler; 2013 Feb; 19(2):254-5. PubMed ID: 22685063
    [No Abstract]   [Full Text] [Related]  

  • 47. Genetical aspects of multiple sclerosis with special regard to histocompatibility determinants.
    Kuwert EK
    Acta Neurol Scand Suppl; 1977; 63():23-42. PubMed ID: 66850
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunogenetic studies of multiple sclerosis patients in Caithness County, Scotland.
    Robertson P; Ward P; Brostoff J; Pack S; Festenstein H; Sacks J; Rosenberg RA; Peters E; Stenning P; Zabriskie JB
    Neuropathol Appl Neurobiol; 1980; 6(4):299-305. PubMed ID: 7413014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lymphocytotoxic and monocytotoxic antibodies in the serum and cerebrospinal fluid of multiple sclerosis patients.
    Rumbach L; Tongio MM; Warter JM; Marescaux C; Mayer S; Rohmer F
    J Neuroimmunol; 1982 Dec; 3(4):263-73. PubMed ID: 6983528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical instrumental and immunological studies of multiple sclerosis in children].
    Evtushenko SK; Efimenko VN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(3):45-9. PubMed ID: 10758648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HLA-A, B and C and HLA-DR antigens in intrinsic and allergic asthma.
    Morris MJ; Faux JA; Ting A; Morris PJ; Lane DJ
    Clin Allergy; 1980 Mar; 10(2):173-9. PubMed ID: 7389070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HLA antigens in multiple sclerosis.
    Brautbar C; Alter M; Kahana E
    Neurology; 1976 Jun; 26(6 PT 2):50-3. PubMed ID: 944895
    [No Abstract]   [Full Text] [Related]  

  • 53. The major histocompatibility system, HLA, and multiple sclerosis.
    Jersild C
    Acta Neurol Scand Suppl; 1977; 63():17-21. PubMed ID: 66848
    [No Abstract]   [Full Text] [Related]  

  • 54. Histocompatibility antigens in multiple sclerosis patients participating in a multicentre trial of azathioprine. British & Dutch Multiple Sclerosis Azathioprine Trial Group.
    J Neurol Neurosurg Psychiatry; 1988 Mar; 51(3):412-5. PubMed ID: 3283297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple sclerosis and high incidence of a B lymphocyte antigen.
    Terasaki PI; Park MS; Opelz G; Ting A
    Science; 1976 Sep; 193(4259):1245-7. PubMed ID: 1085490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Double-blind controlled trial of immunosuppression in the treatment of multiple sclerosis: final report.
    Mertin J; Rudge P; Kremer M; Healey MJ; Knight SC; Compston A; Batchelor JR; Thompson EJ; Halliday AM; Denman M; Medawar PB
    Lancet; 1982 Aug; 2(8294):351-4. PubMed ID: 6124759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased frequency of lymphocytotoxic antibodies in patients with multiple sclerosis correlated with disease activity.
    Tsukamoto T; Ebina T; Takase S; Itahara K; Ishida N
    Tohoku J Exp Med; 1982 Feb; 136(2):121-8. PubMed ID: 6978555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies of HLA alloantigens of the Navajo Indians of North America. I. Variance of association between HLA-DRW (WIA) and HLA-DW specificities.
    Troup GM; Jameson J; Thomsen M; Svejgaard A; Walford RL
    Tissue Antigens; 1978 Jul; 12(1):44-57. PubMed ID: 80839
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histocompatibility determinants in childhood postinfectious encephalomyelitis.
    Woody RC; Steele RW; Charlton RK; Smith V
    J Child Neurol; 1989 Jul; 4(3):204-7. PubMed ID: 2475540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HLA-B12 antigen and multiple sclerosis in a Spanish population (Canary Islands).
    Gantes M; González T
    Tissue Antigens; 1983 Aug; 22(2):172-3. PubMed ID: 6623453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.